Human cytomegalovirus(HCMV) has an infection rate of over 90% in the general population. Although it mostly remains in an asymptomatic latent-infection state, it is the major pathogen responsible for congenital infection in newborns and fatal complications in immunocompromised patients. Currently, the prevention and treatment of HCMV infection face multiple challenges, including drug resistance, toxicity, and immune escape, highlighting the urgent need to integrate novel drugs and therapeutic strategies. The HCMV prevention and treatment strategies are evolving from single antiviral approaches toward multimodal synergistic directions. In the future, it will be necessary to combine structural biology, immune engineering, and clinical translational research to optimize comprehensive intervention systems. This review summarizes the research progress and future prospects of different types of drugs or strategies, including HCMV vaccines, anti-HCMV drugs, HCMV antibody drugs, and specific T-cell infusion therapy, with the aim of providing a reference for optimizing HCMV prevention and treatment strategies.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |